Michael H. Davidson to Societies, Pharmaceutical
This is a "connection" page, showing publications Michael H. Davidson has written about Societies, Pharmaceutical.
Connection Strength
0.021
-
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull. 2010 May; 36(3):504-9.
Score: 0.021